Home / Resource Library / Increased Risk of Cutaneous T-Cell Lymphoma Development after Dupilumab Use for Atopic Dermatitis

Increased Risk of Cutaneous T-Cell Lymphoma Development after Dupilumab Use for Atopic Dermatitis

Study investigated the risk of cutaneous t-cell lymphomas after use of dupilumab for dermatitis.